Bing Zhu

2.8k citations
100 papers · 1.9k indexed · h-index 24
Topics
Pharmacogenetics and Drug Metabolism (16 papers)Multiple Sclerosis Research Studies (14 papers)Inhalation and Respiratory Drug Delivery (9 papers)
Partner nations
United StatesChinaCanada

In The Last Decade

Bing Zhu

95 papers receiving 1.9k citations

Peers

Bing Zhu
Comparison fields: 5 of 136
  • Molecular Biology 440
  • Oncology 421
  • Pharmacology 412
  • Endocrinology, Diabetes and Metabolism 247
  • Pathology and Forensic Medicine 245
Replace Stephan Krähenbühl with:
Stephan Krähenbühl Switzerland
Sorin Ursoniu Romania
Karen Atkinson United States
Keri Wellington New Zealand
Yan Li China
Francisco Abad‐Santos Spain
Kazuko Nakagawa Japan
Ning Li China
Rainer Preiß Germany
Zhicheng Gong China
Bing Zhu relative to Stephan Krähenbühl Switzerland Stephan Krähenbühl's profile →
Citations per field
00.5×1.5×2.1×
Stephan Krähenbühl · 1×
Citations per year

Countries citing papers authored by Bing Zhu

Since Specialization
Citations

This map shows the geographic impact of Bing Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Zhu more than expected).

Fields of papers citing papers by Bing Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Zhu. The network helps show where Bing Zhu may publish in the future.

Co-authorship network of co-authors of Bing Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Zhu. A scholar is included among the top collaborators of Bing Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Zhu. Bing Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 38
4 0
5 1
6 16
7 33
8 15
9 22
10 4
11 3
12 26
13 38
14 17
15 2
16 7
17 1
18 10
19 63
20 6

About Bing Zhu

Bing Zhu is a scholar working on Pharmacology, Microbiology and Pathology and Forensic Medicine, having authored 100 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (16 papers), Multiple Sclerosis Research Studies (14 papers) and Inhalation and Respiratory Drug Delivery (9 papers). The work is most often cited by research in Pharmacology (412 citations), Oncology (421 citations) and Endocrinology, Diabetes and Metabolism (247 citations). Bing Zhu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Xiaoqi Lin, Robert S. Hodges, Nian Zhou, Brian D. Sykes, Song‐Lin Huang, Hong‐Hao Zhou, Giorgio Inghirami, Daniela Traini, Paul M. Young and Jan F. Silverman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026